Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

ApoB and apoM - New aspects of lipoprotein biology in uremia-induced atherosclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Non-AIDS Comorbidity in People Living with HIV Compared to Uninfected Individuals Ten Years Prior to HIV-Diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Apolipoprotein M in patients with chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Chronic kidney disease affects as much as 13% of the population, and is associated with a markedly increased risk of developing cardiovascular disease. One of the underlying reasons is accelerated development of atherosclerosis. This can be ascribed both to increased occurrence of traditional cardiovascular risk factors, and to risk factors that may be unique to patients with chronic kidney disease. The latter is reflected in the observation that the current treatment modalities, mainly directed against traditional risk factors, are insufficient to prevent cardiovascular disease in the patient with chronic kidney disease. This review discusses mechanisms accelerating uremic atherosclerosis with a specific focus on the putative roles of apolipoprotein(apo)s B and M that may be particularly important in patients with chronic kidney disease.

Original languageEnglish
JournalEuropean Journal of Pharmacology
Volume816
Pages (from-to)154-160
Number of pages7
ISSN0014-2999
DOIs
Publication statusPublished - 5 Dec 2017

    Research areas

  • Journal Article

ID: 52077424